| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,634 |
2,532 |
$255K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,453 |
3,375 |
$189K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,571 |
3,778 |
$161K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,288 |
1,288 |
$107K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,356 |
1,349 |
$106K |
| 90461 |
|
1,788 |
1,778 |
$67K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,199 |
1,183 |
$62K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
621 |
621 |
$51K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,248 |
4,240 |
$38K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,004 |
2,984 |
$36K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
461 |
460 |
$34K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,026 |
1,007 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
728 |
725 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,379 |
2,366 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
159 |
159 |
$14K |
| 96127 |
|
1,197 |
1,197 |
$12K |
| 99177 |
|
687 |
687 |
$10K |
| 36416 |
|
926 |
913 |
$9K |
| 99188 |
|
324 |
324 |
$8K |
| 99050 |
|
303 |
301 |
$5K |
| 80061 |
Lipid panel |
346 |
323 |
$4K |
| 83655 |
|
357 |
357 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
128 |
128 |
$3K |
| 81003 |
|
800 |
775 |
$2K |
| 0001A |
|
28 |
27 |
$1K |
| 99051 |
|
73 |
73 |
$1K |
| 0071A |
|
26 |
26 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
42 |
42 |
$992.04 |
| 36415 |
Collection of venous blood by venipuncture |
436 |
424 |
$970.35 |
| 94760 |
|
353 |
351 |
$763.51 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
58 |
$684.98 |
| 0081A |
|
12 |
12 |
$550.56 |
| 83718 |
|
40 |
40 |
$338.00 |
| 87081 |
|
31 |
31 |
$212.04 |
| 92587 |
|
13 |
12 |
$207.72 |
| 82465 |
|
40 |
40 |
$179.20 |
| 87807 |
|
13 |
13 |
$153.53 |
| 99000 |
|
117 |
115 |
$117.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
12 |
12 |
$2.90 |